Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CURA Strategies is a private, bipartisan strategic communications and public affairs firm focused exclusively on health care. The company helps healthcare organizations, advocacy groups, public health programs, health technology companies and pharmaceutical clients shape policy, build stakeholder support, run awareness campaigns, and execute communications, branding, digital, and government relations programs. Its work is services-based rather than drug-development-based, with capabilities spanning research and analysis, communications planning, media relations, advocacy, coalition building, program execution, and corporate communications. CURA has highlighted work across therapeutic and policy areas including mental health, diabetes, obesity, transplantation, opioid recovery, rare disease, and public health initiatives. For a biotech analyst, CURA is best understood as a specialized healthcare communications and policy consultancy rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CURA Strategies.